Monday, July 13, 2020

Cipla gets USFDA nod for rare genetic condition treatment drug

Cipla gets USFDA nod for rare genetic condition treatment drug Cipla#39;s Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire#39;s Firazyr, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3epwuOn

No comments:

Post a Comment

Sensex, Nifty slip 0.7% as Fed’s cautious outlook damps investor sentiment

Indian stock markets experienced a decline on Thursday. The NSE Nifty and BSE Sensex closed lower. This downturn followed the US Federal Res...